North American peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.2% during the forecast period. A significant rise in cancer incidences and increasing prevalence of diabetes are some pivotal factors encouraging market growth. As per the World Health Organization (WHO), in 2018, the number of new cancer incidences reported in North […]
Tag Archives: North American peripheral neuropathy treatment Market
North American peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.2% during the forecast period. An increase in the number of launches for generic peripheral neuropathy drugs to reflect positively on the North America peripheral neuropathy treatment market. For instance, in July 2019, Rising Pharmaceuticals, Inc. declared the introduction of a […]